AU Patent

AU2024204669A1 — Lipid containing formulations

Assigned to Arbutus Biopharma Corp · Expires 2024-07-25 · 2y expired

What this patent protects

Compositions and methods useful in administering nucleic acid based therapies, for example association complexes s such as liposomes and lipoplexes are described.

USPTO Abstract

Compositions and methods useful in administering nucleic acid based therapies, for example association complexes s such as liposomes and lipoplexes are described.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024204669A1
Jurisdiction
AU
Classification
—
Expires
2024-07-25
Drug substance claim
No
Drug product claim
No
Assignee
Arbutus Biopharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.